These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16842385)

  • 1. Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian region.
    Chinellato A; Terrazzani G; Debetto P; Zambon P; Guzzinati S; Walley T; Giusti P
    Br J Clin Pharmacol; 2006 Jul; 62(1):130-3. PubMed ID: 16842385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid prescription for terminally ill outpatients in a district of northern Italy: a retrospective survey.
    Salvato C; Aretini G; Serraglia D; Terrazzani G; Debetto P; Giusti P; Chinellato A
    Pharmacol Res; 2003 Jul; 48(1):75-82. PubMed ID: 12770518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the resources used in advanced cancer care between two different strong opioids: an analysis of naturalistic practice in the UK.
    Guest JF; Ruiz FJ; Russ J; Gupta RD; Mihai A; Greener M
    Curr Med Res Opin; 2005 Feb; 21(2):271-80. PubMed ID: 15801998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate use of high doses of transdermal fentanyl at admission to a palliative care unit.
    Botterman J; Criel N
    Palliat Med; 2011 Mar; 25(2):111-6. PubMed ID: 20937611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validity of recommended minimum dose of prior morphine to initiate transdermal fentanyl patch in prescribing information - multicenter survey of on prescriptions by palliative care specialists in Japan].
    Hashizume T; Tomiyasu S; Yomiya K; Yoshimoto T; Harada A; Matoba M;
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):897-902. PubMed ID: 17570968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
    Sittl R; Nuijten M; Nautrup BP
    Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
    Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A
    J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of fentanyl patch (Durotep) in cancer patients when rotated from morphine preparations].
    Akiyama Y; Iseki M; Izawa R; Ishii K; Miyazaki T; Yamaguchi S; Tani Y
    Masui; 2007 Mar; 56(3):317-23. PubMed ID: 17366919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I.v. infusion of opioids for cancer pain: clinical review and guidelines for use.
    Portenoy RK; Moulin DE; Rogers A; Inturrisi CE; Foley KM
    Cancer Treat Rep; 1986 May; 70(5):575-81. PubMed ID: 2423236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transdermal route as an alternative to oral administration of opioids in cancer pain].
    Burza M; Ginobbi P; Fusco G; Laurenzi L; Tirelli W; Arcuri E
    Clin Ter; 1998; 149(4):277-80. PubMed ID: 9866889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphine.
    Mercadante S; Porzio G; Fulfaro F; Aielli F; Verna L; Ficorella C; Casuccio A; Riina S; Intravaia G; Mangione S
    J Pain Symptom Manage; 2007 Nov; 34(5):532-8. PubMed ID: 17629666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid use in palliative care of children and young people with cancer.
    Hewitt M; Goldman A; Collins GS; Childs M; Hain R
    J Pediatr; 2008 Jan; 152(1):39-44. PubMed ID: 18154896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
    van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
    Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose transdermal buprenorphine - long-term use and co-medication with other potentially addictive drugs.
    Nordbø A; Skurtveit S; Borchgrevink PC; Kaasa S; Fredheim OM
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):88-94. PubMed ID: 22092357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.